SERA
SERA PROGNOSTICS, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.09
+0.72%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $75.0K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$0.15
- Revenue actual
- $30.0K
- Revenue estimate
- $71.4K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +2.3%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.15 | -$0.18 | Miss -16.72% | $30.0K |
| May 6, 2026 | -$0.16 | -$0.17 | Miss -6.25% | $14.0K |
| Mar 18, 2026 | -$0.19 | -$0.16 | Beat 16.56% | $10.0K |
| Nov 13, 2025 | -$0.19 | -$0.16 | Beat 15.79% | $16.0K |
| Aug 6, 2025 | -$0.21 | -$0.16 | Beat 23.81% | $17.0K |
| May 7, 2025 | -$0.24 | -$0.20 | Beat 16.67% | $38.0K |
| Mar 19, 2025 | -$0.23 | -$0.25 | Miss -8.70% | $24.0K |
| Mar 20, 2024 | -$0.25 | -$0.25 | In line | $41.0K |
| Mar 22, 2023 | -$0.42 | -$0.31 | Beat 26.19% | $65.0K |
| Nov 9, 2022 | -$0.40 | -$0.35 | Beat 12.50% | $87.0K |
| Aug 10, 2022 | -$0.40 | -$0.37 | Beat 7.50% | $78.0K |
| Aug 30, 2021 | -$1.26 | -$3.17 | Miss -151.59% | $20.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026